NO20006559L - Farmasöytisk kombinasjon omfattende en cox-2-inhibitor og en iNOS-inhibitor - Google Patents

Farmasöytisk kombinasjon omfattende en cox-2-inhibitor og en iNOS-inhibitor

Info

Publication number
NO20006559L
NO20006559L NO20006559A NO20006559A NO20006559L NO 20006559 L NO20006559 L NO 20006559L NO 20006559 A NO20006559 A NO 20006559A NO 20006559 A NO20006559 A NO 20006559A NO 20006559 L NO20006559 L NO 20006559L
Authority
NO
Norway
Prior art keywords
inhibitor
cox
pharmaceutical combination
inos
inos inhibitor
Prior art date
Application number
NO20006559A
Other languages
English (en)
Norwegian (no)
Other versions
NO20006559D0 (no
Inventor
Peter Hamley
Alan Tinker
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20006559D0 publication Critical patent/NO20006559D0/no
Publication of NO20006559L publication Critical patent/NO20006559L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20006559A 1998-06-29 2000-12-21 Farmasöytisk kombinasjon omfattende en cox-2-inhibitor og en iNOS-inhibitor NO20006559L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9802333A SE9802333D0 (sv) 1998-06-29 1998-06-29 Novel combination
PCT/SE1999/001144 WO2000000200A1 (en) 1998-06-29 1999-06-23 A PHARMACEUTICAL COMBINATION COMPRISING A COX-2 INHIBITOR AND A iNOS INHIBITOR

Publications (2)

Publication Number Publication Date
NO20006559D0 NO20006559D0 (no) 2000-12-21
NO20006559L true NO20006559L (no) 2001-02-28

Family

ID=20411898

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20006559A NO20006559L (no) 1998-06-29 2000-12-21 Farmasöytisk kombinasjon omfattende en cox-2-inhibitor og en iNOS-inhibitor

Country Status (22)

Country Link
US (1) US6248745B1 (id)
EP (1) EP1100505A1 (id)
JP (1) JP2002519324A (id)
KR (1) KR20010053252A (id)
CN (1) CN1313769A (id)
AU (1) AU4944799A (id)
BR (1) BR9911666A (id)
CA (1) CA2334515A1 (id)
CZ (1) CZ20004896A3 (id)
EE (1) EE200000766A (id)
ID (1) ID27394A (id)
IL (1) IL140022A0 (id)
IN (1) IN2000MU00721A (id)
IS (1) IS5794A (id)
MX (1) MXPA00012162A (id)
NO (1) NO20006559L (id)
PL (1) PL345028A1 (id)
SE (1) SE9802333D0 (id)
SK (1) SK18482000A3 (id)
TR (1) TR200003808T2 (id)
WO (1) WO2000000200A1 (id)
ZA (1) ZA200007076B (id)

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2299441T3 (es) * 1999-12-08 2008-06-01 Pharmacia Corporation Forma en estado solido de celecoxib con biodisponibilidad potenciada.
CN100486573C (zh) 1999-12-23 2009-05-13 硝化医药股份有限公司 硝基化的和亚硝基化的环加氧酶-2抑制剂、组合物及其用途
US6706724B2 (en) * 2000-12-21 2004-03-16 Nitromed, Inc. Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use
US7012098B2 (en) * 2001-03-23 2006-03-14 Pharmacia Corporation Inhibitors of inducible nitric oxide synthase for chemoprevention and treatment of cancers
BR0306726A (pt) * 2002-01-07 2004-12-21 Pharmacia Corp Mistura de fármacos com melhor taxa de dissolução
WO2003103602A2 (en) * 2002-06-11 2003-12-18 Nitromed, Inc. Nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use
US20040077691A1 (en) * 2002-06-21 2004-04-22 Medinox, Inc. Hydroxamate derivatives of non-steroidal anti-inflammatory drugs
US7163958B2 (en) 2002-07-03 2007-01-16 Nitromed Inc. Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
AU2003261281A1 (en) * 2002-07-29 2004-02-16 Nicox S.A. Cyclooxygenase- 2 selective inhibitors, compositions and methods of use
AU2003260033A1 (en) * 2002-08-29 2004-03-19 Schering Aktiengesellschaft Methods of treating acute respiratory distress syndrome
EP2266585B1 (en) 2003-05-07 2013-06-26 Osteologix A/S Water-soluble strontium salts for use in treatment of cartilage and/or bone conditions
US8173642B2 (en) 2005-10-25 2012-05-08 Shionogi & Co., Ltd. Aminodihydrothiazine derivatives
JP2007275193A (ja) * 2006-04-04 2007-10-25 Fujifilm Corp 光プローブおよび光断層画像化装置
EP2083579B1 (en) 2006-10-25 2014-02-12 Huawei Technologies Co., Ltd. Processing location update request method, network entity, congestion control method and apparatus
WO2008091530A2 (en) * 2007-01-19 2008-07-31 Mallinckrodt Inc. Diagnostic and therapeutic cyclooxygenase-2 binding ligands
JP5383484B2 (ja) 2007-04-24 2014-01-08 塩野義製薬株式会社 環式基で置換されたアミノジヒドロチアジン誘導体
EP2151435A4 (en) 2007-04-24 2011-09-14 Shionogi & Co PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ALZHEIMER'S DISEASE
WO2009120186A1 (en) * 2008-03-24 2009-10-01 Carolus Therapeutics, Inc. Methods and compositions for treating atherosclerosis and related conditions
CN102119161B (zh) 2008-06-13 2015-07-08 盐野义制药株式会社 具有β分泌酶抑制作用的含硫杂环衍生物
JPWO2010047372A1 (ja) 2008-10-22 2012-03-22 塩野義製薬株式会社 Bace1阻害活性を有する2−アミノピリミジン−4−オンおよび2−アミノピリジン誘導体
US8453441B2 (en) 2008-11-06 2013-06-04 Purdue Research Foundation System and method for pump-controlled cylinder cushioning
MY145791A (en) * 2009-05-25 2012-04-30 Liang Woon San A method for producing a nutraceutical composition and the nutraceutical produced by the method
CN102834384A (zh) 2009-12-11 2012-12-19 盐野义制药株式会社 *嗪衍生物
US20120258961A1 (en) * 2009-12-24 2012-10-11 Shionogi & Co., Ltd. 4-amino-1,3-thiazine or oxazine derivative
US9040277B2 (en) 2010-01-13 2015-05-26 Basf Se Mannanase variants
US8883461B2 (en) 2010-03-12 2014-11-11 Council Of Scientific & Industrial Research Process for the production of violacein and its derivative deoxyviolacein containing bioactive pigment from Chromobacterium sp. (MTCC5522)
DE102010030500A1 (de) 2010-06-24 2011-12-29 Heliatek Gmbh Verdampfbares organisch halbleitendes Material und dessen Verwendung in einem optoelektronischen Bauelement
JP5816630B2 (ja) 2010-10-29 2015-11-18 塩野義製薬株式会社 ナフチリジン誘導体
EP2634188A4 (en) 2010-10-29 2014-05-07 Shionogi & Co FUSIONED AMINODIHYDROPYRIMIDINE DERIVATIVE
DE102011018604A1 (de) 2011-04-25 2014-02-13 Michael Friebe Medikamenteninfusor für die Anwendung in stark magnetischen Umgebungen
US8883779B2 (en) 2011-04-26 2014-11-11 Shinogi & Co., Ltd. Oxazine derivatives and a pharmaceutical composition for inhibiting BACE1 containing them
EP2713937A1 (de) 2011-06-01 2014-04-09 Josef Schweiger Verbundkrone/verbundbrücke und verfahren zu deren herstellung
PL2764016T3 (pl) 2011-10-07 2019-08-30 Lonza Ltd Regulowany promotor
DE102012201426A1 (de) 2012-02-01 2013-08-01 Leibniz-Institut Für Polymerforschung Dresden E.V. Verfahren zum verbinden von kunststoffen und verfahren zum lösen einer verbindung im kunststoffverbund und kunststoffverbund
DE102012007141A1 (de) 2012-04-10 2013-10-10 Bernhard Spindler Jalousierbarer Rollladenpanzer
DE102012106428A1 (de) 2012-07-17 2014-01-23 Reha Technology GmbH Vorrichtung zur therapeutischen Behandlung, System zur gerätegestützten Lokomotionstherapie und Verfahren zur Steuerung der Vorrichtung
WO2014024034A1 (es) 2012-08-08 2014-02-13 Choque Alberto Pati Compostaje de residuos sólidos, liquidos y lodos biodegradables mediante humus de lombriz (eisenia foetida y especies similares) y mezclas de humus de lombriz y material estomacal con alto contenido de microrganismos
DE102012214452B4 (de) 2012-08-14 2019-08-01 Henkel Ag & Co. Kgaa Vorrichtung zum Auftragen einer fadenförmigen Masse
DE102012016116A1 (de) 2012-08-15 2014-02-20 Josip Fellner 360° Bag ln Box Spendersystem
DE102012214554A1 (de) 2012-08-16 2014-02-20 Robert Bosch Gmbh Verfahren zur Überführung von Batterien in einen entladenen Zustand, Batteriemanagementsystem, Inverter, System zur Erzeugung einer Wechselspannung, Ladestromquelle und Kraftfahrzeug
DE102012108153A1 (de) 2012-09-03 2014-03-06 Ludwig-Maximilians-Universität München Rohling und Verfahren zur Herstellung einer Dentalrestauration durch substraktive Bearbeitung
WO2014065434A1 (en) 2012-10-24 2014-05-01 Shionogi & Co., Ltd. Dihydrooxazine or oxazepine derivatives having bace1 inhibitory activity
DE102012112186A1 (de) 2012-12-12 2014-06-26 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Materialverbund, Verfahren zu dessen Herstellung, daraus hergestelltes System und Anwendung desselben
EP2956041A2 (de) 2013-02-15 2015-12-23 Jochen Mertens Mixer mit massnahmen zur reduzierung des eintrages von luftsauerstoff in den mixer-inhalt
DE102013101713B4 (de) 2013-02-21 2020-10-01 Heliatek Gmbh Photoaktives, organisches Material für optoelektronische Bauelemente
DE102013101712B4 (de) 2013-02-21 2020-05-28 Heliatek Gmbh Photoaktives organisches Material für optoelektronische Bauelemente
DE102013102365A1 (de) 2013-03-10 2014-09-11 Informium Ag Identifikationsmerkmal mit integriertem Kopierschutz
DE102013102364A1 (de) 2013-03-10 2014-09-11 Informium Ag Verfahren zur Herstellung eines Identifikationsmerkmals mit integriertem Kopierschutz
DE102013102366A1 (de) 2013-03-10 2014-09-11 Informium Ag Vorrichtungen zur Herstellung und zum Auslesen eines Identifikationsmerkmals mit integriertem Kopierschutz
DE102013004288A1 (de) 2013-03-13 2014-09-18 Matthias Lietzau Fahrzeug Verbindungsfolie
DE202013002767U1 (de) 2013-03-22 2013-05-28 Lorenz-Montagesysteme Gmbh Ausgleichende Seitverbindung von Solarmodulen
DE102013005741B3 (de) 2013-04-05 2014-05-22 IOT - Innovative Oberflächentechnologien GmbH Vorrichtung zur Inertisierung bei UV-Bestrahlung in offenen Durchlaufanlagen
EP2792394B1 (de) 2013-04-16 2016-07-27 Jörg Beutler Interaktive Geschwindigkeitssteuerung
DE102013104501A1 (de) 2013-05-02 2014-11-06 B. Braun Avitum Ag Vorrichtung zur extrakorporalen Blutbehandlung
DE102013008359A1 (de) 2013-05-16 2014-11-20 Sew-Eurodrive Gmbh & Co Kg Energiespeicher, der aus in Reihe geschalten Energiespeicherzellen aufgebaut ist, und Schaltungsanordnung zur passiven Symmetrierung einer Reihenschaltung von Kondensatoren
DE102013008919B4 (de) 2013-05-24 2017-12-07 Magdeburger Windkraftanlagen GmbH Rotorsystem für die Energiewandlung von kinetischer Energie in Fluiden und Massenströmen
DE202013006258U1 (de) 2013-07-11 2013-10-11 IMM Ingenieurbüro GmbH Vorrichtung zum Erzeugen von heizbaren Flächen mit homogener Wärmeverteilung
DE102013110693B4 (de) 2013-09-27 2024-04-25 Heliatek Gmbh Photoaktives, organisches Material für optoelektronische Bauelemente
EP2873807A1 (de) 2013-11-18 2015-05-20 Siemens Aktiengesellschaft Abdeckplatte, Laufschaufel, Radscheibe, Bolzen und Gasturbine
EP3071392B1 (de) 2013-11-19 2019-09-25 Fraunhofer Gesellschaft zur Förderung der Angewand Verfahren zum verbinden von silikongummi mit einem substrat
EP2902692B1 (de) 2013-12-06 2017-10-25 MAGNA STEYR Engineering AG & Co KG Bauteil eines Tanksystems
DE202014100570U1 (de) 2014-02-10 2014-03-10 Schlaadt Plastics Gmbh Klappsystem zur Verbindung von Partikelschaumbauteilen mittels eines gegen Verlust gesicherten Steckelements
DE102014004280A1 (de) 2014-03-26 2015-10-01 Florian M. König Impulssignal-Erzeugungsvorrichtung für Zwecke der autonomen Batterieaufladung oder 120-/230-Volt-Lampenversorgung
DE202014003299U1 (de) 2014-04-14 2014-08-25 Antje Koss Stollenschuh mit Wechselstollensystem
DE202014004532U1 (de) 2014-05-28 2014-08-05 Hans-Dieter Cornelius Hygienevorlage
DE102015214637A1 (de) 2014-11-10 2016-05-12 Hermann Roth Vorrichtung zur Erzeugung eines alkaloidhaltigen Aerosols
DE102014017938A1 (de) 2014-12-05 2016-06-09 Florian M. König Trichter-turbinenartige Vorrichtung mit elektromagnetischer Rotationssteuerung von Flüssigkeits-Mischvorgängen
DE102015000003A1 (de) 2015-01-02 2016-07-07 Solukon Ingenieure GbR (vertretungsberechtigte Gesellschafter: Andreas Hartmann, 86391 Stadtbergen und Dominik Schmid, 86165 Augsburg) Baubehälter für Produktionsanlagen zur Herstellung von Bauteilen in Schichtbauverfahren
DE102015008129A1 (de) 2015-01-22 2016-07-28 Liebherr-Hausgeräte Lienz Gmbh Verfahren zur Bestimmung der Dämmeigenschaft einer Wandung eines wärmeisolierten Behältnisses
DE102015000887A1 (de) 2015-01-23 2016-07-28 Arnulf Deinzer Zahnreinigungsgerät mit ausfahrbaren Borsten
DE102015015877A1 (de) 2015-12-09 2017-06-14 Bayerisches Zentrum für angewandte Energieforschung, e.V. (ZAE Bayern) Optisch schaltendes Element
DE102016006696A1 (de) 2016-05-27 2017-11-30 Christoph Jaeger Flugautosystem
DE202016004226U1 (de) 2016-07-06 2016-11-11 Helmut Senkel Schienensystem mit verfahrbaren Verbrauchern
CN106279585A (zh) * 2016-08-26 2017-01-04 宁波圣达精工智能科技有限公司 一种阻燃智能密集书架的制备方法
CN108832306B (zh) * 2018-06-13 2023-11-03 中国科学院国家天文台 一种fast反射面中心孔柔性封堵结构

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997014686A1 (en) * 1995-10-17 1997-04-24 Astra Pharmaceuticals Limited Pharmaceutically active quinazoline compounds

Also Published As

Publication number Publication date
US6248745B1 (en) 2001-06-19
CA2334515A1 (en) 2000-01-06
ID27394A (id) 2001-04-05
PL345028A1 (en) 2001-11-19
ZA200007076B (en) 2002-02-28
WO2000000200A1 (en) 2000-01-06
SE9802333D0 (sv) 1998-06-29
IS5794A (is) 2000-12-27
CZ20004896A3 (en) 2001-06-13
KR20010053252A (ko) 2001-06-25
MXPA00012162A (es) 2001-05-01
JP2002519324A (ja) 2002-07-02
BR9911666A (pt) 2001-03-20
AU4944799A (en) 2000-01-17
IL140022A0 (en) 2002-02-10
NO20006559D0 (no) 2000-12-21
EP1100505A1 (en) 2001-05-23
IN2000MU00721A (id) 2005-03-18
CN1313769A (zh) 2001-09-19
TR200003808T2 (tr) 2001-06-21
SK18482000A3 (sk) 2001-07-10
EE200000766A (et) 2002-06-17

Similar Documents

Publication Publication Date Title
NO20006559L (no) Farmasöytisk kombinasjon omfattende en cox-2-inhibitor og en iNOS-inhibitor
NO20001830L (no) Ny kombinasjon
CY1120241T1 (el) Χρησιμοποιηση εψιδινης για την παρασκευη ενος φαρμακου για τη θεραπεια διαταραχων της ομοιοστασης του σιδηρου
IL160065A0 (en) 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
NO994778D0 (no) FremgangsmÕter og sammensetninger for behandling av tarmbetennelse
BR9809819A (pt) Compostos e métodos para a inibição da expressão de vcam-1
NO20024528L (no) Proteaseinhibitor, farmasoytisk sammensetning og anvendelse av forbindelsen
AU2001284690A1 (en) Compositions exhibiting synergistic inhibition of the expression and/or activityof cyclooxygenase-2
NO20024610L (no) Synergistiske metoder og blandinger for behandling av kreft
NO20033002D0 (no) Nye kinuklidinderivater og medisinske sammensetninger inneholdende det samme
NO20031407L (no) Glukopyranosyloksybenzylbenzen-derivater og medisinske sammensetninger inneholdende det samme
LV11865A (lv) Kompozicijas un panemieni tuklo sunu iekaisumu arstesanai
NO20030397L (no) Amyloid målsökende billeddannende midler og anvendelser av samme
NO20014314L (no) Blandinger og metoder for behandling av stafylokokkisk infeksjon
NO20015516L (no) Preparater og anvendelser av ET743 for behandling av kreft
TR199801511T2 (xx) Farmas�tik bile�im.
EE05056B1 (et) IL-18 inhibiitorite kasutamine ravimi valmistamiseks, mis on ette n„htud ateroskleroosi ravimiseks ja/v?i ennetamiseks
NO20013507L (no) Blandinger for behandling av inflammatoriske reaksjoner
ATE429224T1 (de) Arzneizubereitungen enthaltend mindestens einen hiv preoteaseinhibitor
NO20010487D0 (no) Disubstituert maleimidforbindelse og farmasöytisk anvendelse herav
NO20014648D0 (no) Forbindelser og metoder for behandling av astma, allergi og inflammatoriske sykdommer
NO20010291D0 (no) Coadministrasjon av ACAT og MMP inhibitorer for behandling av aterosklerotiske sår
NO20023737L (no) Fremgangsmåte og preparater for behandling av en inflammatorisk lidelse
NO20020326L (no) Sammensetning og anvendelse av en inhibitor av PPAR-delta-aktivitet
AU2001267404A1 (en) Novel compounds for the treatment of inflammatory and cardiovascular diseases

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application